FERRARI, Anna
 Distribuzione geografica
Continente #
EU - Europa 28.314
NA - Nord America 25.061
AS - Asia 10.804
SA - Sud America 1.833
AF - Africa 292
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 32
Totale 66.388
Nazione #
US - Stati Uniti d'America 24.577
IT - Italia 17.845
GB - Regno Unito 3.950
CN - Cina 3.133
SG - Singapore 2.958
NL - Olanda 1.375
BR - Brasile 1.370
VN - Vietnam 1.314
HK - Hong Kong 1.245
SE - Svezia 880
DE - Germania 862
FR - Francia 695
UA - Ucraina 656
FI - Finlandia 541
RU - Federazione Russa 437
KR - Corea 406
TR - Turchia 393
IN - India 259
BG - Bulgaria 231
BD - Bangladesh 227
CA - Canada 224
CH - Svizzera 222
MX - Messico 158
ID - Indonesia 145
AR - Argentina 129
ES - Italia 91
JP - Giappone 90
IE - Irlanda 84
IQ - Iraq 80
EC - Ecuador 77
ZA - Sudafrica 68
PL - Polonia 67
PK - Pakistan 66
CO - Colombia 64
CL - Cile 60
IR - Iran 55
AU - Australia 48
BE - Belgio 46
EG - Egitto 45
CZ - Repubblica Ceca 43
MY - Malesia 43
PH - Filippine 43
AE - Emirati Arabi Uniti 42
MA - Marocco 42
PE - Perù 40
SA - Arabia Saudita 39
TW - Taiwan 36
VE - Venezuela 36
UZ - Uzbekistan 33
GR - Grecia 31
TN - Tunisia 31
PY - Paraguay 29
AT - Austria 25
DZ - Algeria 25
KE - Kenya 25
EU - Europa 24
RO - Romania 24
SK - Slovacchia (Repubblica Slovacca) 24
CR - Costa Rica 23
TH - Thailandia 23
DK - Danimarca 22
HU - Ungheria 22
PT - Portogallo 21
RS - Serbia 21
NP - Nepal 20
LT - Lituania 19
BO - Bolivia 18
DO - Repubblica Dominicana 18
JM - Giamaica 18
AZ - Azerbaigian 16
JO - Giordania 16
IL - Israele 14
NO - Norvegia 12
AL - Albania 11
KZ - Kazakistan 11
NG - Nigeria 11
SN - Senegal 11
OM - Oman 10
PR - Porto Rico 10
BY - Bielorussia 9
ET - Etiopia 9
KG - Kirghizistan 9
LB - Libano 9
PA - Panama 9
UY - Uruguay 9
GE - Georgia 8
MN - Mongolia 8
SI - Slovenia 8
BH - Bahrain 7
LU - Lussemburgo 7
LV - Lettonia 7
QA - Qatar 7
AM - Armenia 6
EE - Estonia 6
HN - Honduras 6
PS - Palestinian Territory 6
YE - Yemen 6
HR - Croazia 5
KW - Kuwait 5
MK - Macedonia 5
Totale 66.306
Città #
Southend 2.835
Ashburn 2.139
Santa Clara 1.974
Milan 1.942
Fairfield 1.875
Singapore 1.844
Woodbridge 1.381
Jacksonville 1.286
Hong Kong 1.220
Chandler 1.146
Houston 965
Hefei 870
Rome 765
Wilmington 735
Ann Arbor 727
Dearborn 708
Chicago 705
Seattle 704
Beijing 660
Cambridge 645
Jersey City 590
San Jose 569
London 503
Los Angeles 502
Turin 496
Nyköping 476
Ho Chi Minh City 437
Seoul 338
Helsinki 329
The Dalles 308
Hanoi 304
Salt Lake City 286
Council Bluffs 273
Florence 257
Princeton 255
Modena 242
Genoa 232
Sofia 220
Brescia 218
New York 210
Eugene 206
Bologna 204
Izmir 199
Lauterbourg 181
San Diego 176
Dallas 161
Moscow 150
Redwood City 144
Elk Grove Village 140
Naples 131
Tampa 129
São Paulo 123
Buffalo 120
Orem 109
Verona 107
Bergamo 103
Shanghai 94
Frankfurt am Main 87
Monza 86
Sterling 85
Jakarta 81
Trenton 80
Falls Church 77
Dublin 76
Des Moines 74
Perugia 74
Da Nang 72
Padova 71
Parma 70
Palermo 66
Lancaster 64
Pescara 63
Boardman 61
Columbus 61
Chennai 60
Tokyo 60
Catania 58
Miami 58
Norwalk 56
Bari 55
Haiphong 54
Guangzhou 53
Toronto 53
Brooklyn 51
Munich 50
Trieste 49
Venice 48
Mexico City 46
Nanjing 46
Phoenix 46
Fremont 45
Dulles 44
Paris 42
Bremen 41
Detroit 41
Reggio Emilia 41
Rio de Janeiro 40
Ancona 37
Lucca 37
Torino 37
Totale 37.144
Nome #
Monitoraggio dei pazienti con uso/abuso alcolico mediante la determinazione dell'Etil glucuronide (EtG) nel capello 10.648
Krokodil: The drug that kills 6.041
La flunarizina nella profilassi delel crisi emicraniche delle cefalee cclassiche e comuni 2.167
Atogepant: an emerging treatment for migraine 960
Allopregnanolone serum levels in female migraineurs 788
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors 723
Seizures of illicit substances for personal use in two Italian provinces: analysis of trends by type and purity from 2008 to 2017 669
Development and validation of a liquid chromatography-tandem mass spectrometric assay for quantitative analyses of triptans in hair 508
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 489
Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients 484
Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats 477
Effective prophylactic treatments of migraine lower plasma glutamate levels 457
Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study 457
Methadone - metabolism, pharmacokinetics and interactions 443
Past, present, and future prospects of medication-overuse headache classification 427
Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study 423
Tramadol chronic abuse: An evidence from hair analysis by LC tandem MS 421
Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients 418
Clinical pharmacology of topiramate in migraine prevention 411
OPPIACEI: FARMACOCINETICA, DIPENDENZA, DETOSSIFICAZIONE, TRATTAMENTI AGONISTI ED ANTAGONISTI 410
How children and parents evaluate the headache centre's intervention 405
Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ) 403
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 398
Monitoring of adherence to headache treatments by means of hair analysis 397
Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments 395
Medication overuse and chronic migraine: a critical review according to clinical pharmacology 395
Effect of sumatriptan in different models of pain in rats 390
Hair testing in clinical setting: simultaneous determination of 50 psychoactive drugs and metabolites in headache patients by LC tandem MS 382
Similarities and differences between chronic migraine and episodic migraine 379
Hair analysis to monitor abuse of analgesic combinations containing butalbital and propyphenazone 379
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 374
Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments 368
Paracetamol: new vistas of an old drug 367
Prevalence of abuse of alcohol and other drugs among injured drivers presenting to the emergency department of the University Hospital of Modena, Italy 360
Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study 358
Basal cutaneous pain threshold in headache patients 357
Adverse reactions related to drugs for headache treatment: clinical impact 354
Headache: one of the most common and troublesome adverse reactions to drugs. 348
Serum time course of naltrexone and 6 beta-naltrexol levels during long term treatment in drug addicts 346
Diagnostic accuracy of hair analysis for the detection of triptan overuse in migraineurs 339
Paracetamol revisited 325
Le neuropatie da farmaci 324
Analgesic drug taking: Beliefs and behavior among headache patients 321
Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage 317
Farmacologia e Tossicologia 298
Abuse of tramadol in a binge pattern in a young woman 298
Sucrose intake: Increase in non-stressed rats and reduction in chronically stressed rats are both prevented by the gamma-hydroxybutyrate (GHB) analogue, GET73 295
Zopiclone and prazepam dependance: role of hair analysis for the monitoring of treatment in a migraine patient 294
Topiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: a case-report 287
Focus on headache as an adverse reaction to drugs 280
Intrapatient variability of the hair levels of pain medications in chronic migraine patients - a pilot study 280
Valutazione del contenuto plasmatico e possibile uso terapeutico del glutatione in pazienti con cefalea cronica quotidiana ed uso giornaliero di associazioni analgesiche 274
Pharmacokinetics of indomethacin in chronic migraine patients after withdrawal from the overused combination of indomethacin, Prochlorperazine and caffeine 272
Italian guidelines for primary headaches: 2012 revised version. 271
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 266
Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. 265
Pharmacoepidemiology of triptans in a headache centre 264
Polypharmacy Among Headache Patients: A Cross-Sectional Study 262
Different effect of sumatriptan in models of thermal, chemical or cephalalgic pain, in rats 262
Abuso di sostanze psicoattive e sistema neuroendocrino dell’adolescente 261
Emerging problems in the pharmacology of migraine: interactions between triptans and drugs for prophylaxis 257
Dehydroepiandrosterone Sulfate, Dehydroepiandrosterone, 5α-Dihydroprogesterone and Pregnenolone: Serum Analysis and Correlation Between Migraine and Non-headache Control Females 255
Glutamate receptor antagonists with the potential for migraine treatment 251
Hair testing as a marker of adherence to headache treatments 250
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 250
Proteomic serum profile in menstrual-related and post menopause migraine 250
Analgesic abuse in chronic headache sufferers 248
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. 248
Oral delivery of insulin loaded into polymeric nanoparticles in rats. 244
Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review 241
INFLUENCE OF PROLONGED THERAPY WITH FLUNARIZINE ON GLUCOSE, INSULIN AND C-PEPTIDE METABOLISM 240
Adolescenza, sostanze stupefacenti, riti di passaggio 233
Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study 233
Assessment of the efficacy and tolerability of triptans in clinical practice 231
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 230
Activity of cromolyn sodium in dietary migraine: a double-blind placebo controlled multicenter trial 229
Pharmacological outline of chronic headache patients: overlap between depressive and nociceptive symptomatology 229
Evalutation of proteomic profile in menstrually-related migraine 229
Accanimento terapeutico o riduzione del danno 225
Tramadol Abuse in a Binge Pattern in a Young Depressed Woman 224
Azioni, interazioni, controindicazioni, tossicità dei farmaci utilizzati nella terapia dell'emicrania 223
CHRNA5 polymorphism and nicotine dependence in patients with cluster headache 223
Plasma glutathione level in chronic headache drug abuser patients 222
Clinical considerations preliminary to application of the Italian Society for the Study of Headache’s guidelines regarding migraine prophylactic treatment 222
Trattamento farmacologico del dolore postoperatorio 218
Hypertension and migraine comorbidity: Prevalence and risk of cerebrovascular events: Evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study) 218
Plasma glutathione level in paracetamol daily abuser patients. Changes in plasma cysteine and thiol groups after reduced glutathione administration 213
Trattamento farmacologico integrato per la terapia delle tossicodipendenze 213
Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study 213
Drug metabolism in liver cirrhosis: alterations of the time-course of plasma naltrexone levels after oral intake 212
Folate, vitamin B12, and serum homocysteine levels in patients with chronic migraine and medication-overuse headache 211
Proteomic serum profile of female migraineurs 211
Zopiclone and prazepam abuse in a chronic migraine patient 209
Evaluation of proteomic profile in menstrual-related migraine 208
Dehydroepiandrosterone sulfate, dehydroepiandrosterone, 5α-dihydroprogesterone and pregnenolone in women with migraine: analysis of serum levels and correlation with age, migraine years and frequency 208
Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients 205
Headache as an Adverse Reaction to Medication 202
Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey 202
Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study 198
Storia della Sindrome di Neri Barrè 196
Totale 50.055
Categoria #
all - tutte 194.012
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 194.012


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021701 0 0 0 0 0 0 0 0 0 0 448 253
2021/20224.493 169 519 430 465 191 223 256 296 449 315 568 612
2022/20235.226 494 438 281 409 526 604 248 531 682 252 426 335
2023/20246.492 276 362 371 578 746 468 719 722 389 501 685 675
2024/202512.633 679 491 494 937 1.951 1.498 1.029 909 1.428 869 1.196 1.152
2025/202620.431 1.890 1.183 1.817 2.773 3.635 1.370 2.194 1.255 1.611 1.573 1.130 0
Totale 66.651